Walgreens Boots Alliance (NASDAQ:WBA) Releases FY 2025 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.400-1.800 for the period, compared to the consensus earnings per share estimate of 1.750. The company issued revenue guidance of $147.0 billion-$151.0 billion, compared to the consensus revenue estimate of $147.3 billion. Walgreens Boots Alliance also updated its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Trading Up 15.8 %

NASDAQ WBA opened at $10.42 on Wednesday. The firm has a 50-day moving average price of $9.40 and a two-hundred day moving average price of $13.23. Walgreens Boots Alliance has a 12-month low of $8.22 and a 12-month high of $27.05. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31.

Analyst Ratings Changes

A number of brokerages recently issued reports on WBA. Morgan Stanley reduced their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an underweight rating on the stock in a research report on Friday, October 11th. JPMorgan Chase & Co. reduced their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an overweight rating on the stock in a report on Friday, August 30th. Barclays reduced their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an underweight rating on the stock in a research note on Tuesday, July 23rd. UBS Group decreased their target price on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a neutral rating on the stock in a report on Wednesday, July 3rd. Finally, Evercore ISI reduced their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an in-line rating on the stock in a research report on Friday, June 28th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of Hold and an average price target of $13.46.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.